Jet.AI Inc. Files S-1/A Amendment
Ticker: JTAI · Form: S-1/A · Filed: Sep 26, 2024 · CIK: 1861622
Sentiment: neutral
Topics: sec-filing, amendment, company-update
TL;DR
Jet.AI Inc. (formerly Oxbridge) filed an S-1/A update on 9/26. Financials for 6/30/24 and 12/31/23 included.
AI Summary
Jet.AI Inc. filed an S-1/A amendment on September 26, 2024, detailing its business operations and financial status. The company, formerly Oxbridge Acquisition Corp., is based in Las Vegas, NV, and operates in the air transportation sector. The filing includes financial data for periods ending June 30, 2024, and December 31, 2023, with references to preferred stock and related party transactions.
Why It Matters
This filing provides updated information for investors and the public regarding Jet.AI Inc.'s financial health and corporate structure, crucial for understanding its current market position and future prospects.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it indicates a company in the process of offering securities or making significant updates, which inherently carries investment risk.
Key Numbers
- 333-279385 — SEC File Number (Identifies the specific SEC registration)
- 0001861622 — Central Index Key (Unique identifier for the filer)
Key Players & Entities
- Jet.AI Inc. (company) — Filer
- Oxbridge Acquisition Corp. (company) — Former company name
- 20240926 (date) — Filing date
- LAS VEGAS, NV (location) — Business address
- 702-747-4000 (phone_number) — Business phone
- 2024-06-30 (date) — Financial reporting period end
- 2023-12-31 (date) — Financial reporting period end
FAQ
What is the primary business of Jet.AI Inc.?
Jet.AI Inc. operates in the air transportation sector, specifically nonscheduled air transport.
When was Jet.AI Inc. formerly known as?
Jet.AI Inc. was formerly known as Oxbridge Acquisition Corp., with a name change date of May 11, 2021.
What is the business address of Jet.AI Inc.?
The business address is 10845 Griffith Peak Dr., Suite 200, Las Vegas, NV 89135.
What financial periods are referenced in the filing?
The filing references financial data for periods ending June 30, 2024, December 31, 2023, and December 31, 2022.
What is the SEC Act under which this filing is made?
This filing is made under the Securities Act of 1933.
Filing Stats: 4,616 words · 18 min read · ~15 pages · Grade level 15.8 · Accepted 2024-09-26 17:24:58
Key Financial Figures
- $0.0001 — 2 shares of our common stock, par value $0.0001 per share ("Common Stock"), by the sell
- $0.108 — price of our Common Stock on Nasdaq was $0.108 per share. We may amend or supplement
- $10,000 — Preferred Stock at an exercise price of $10,000 per share, and (c) 250,000 shares of Co
- $1.5 m — eceived gross proceeds of approximately $1.5 million, not including customary placemen
- $15.0 million — itional gross proceeds of approximately $15.0 million. The Company cannot predict when or if
- $100 — ying to the Selling Stockholder in cash $100 per share of Series B Preferred Stock t
- $100,000 — pay to the Selling Stockholder a fee of $100,000 (the "Effectiveness Fee"). On September
Filing Documents
- forms-1a.htm (S-1/A) — 2884KB
- ex5-1.htm (EX-5.1) — 22KB
- ex107.htm (EX-FILING FEES) — 17KB
- forms-1_001.jpg (GRAPHIC) — 7KB
- audit_003.jpg (GRAPHIC) — 18KB
- audit_002.jpg (GRAPHIC) — 10KB
- audit_001.jpg (GRAPHIC) — 7KB
- ex5-1_001.jpg (GRAPHIC) — 10KB
- 0001493152-24-038376.txt ( ) — 9280KB
- jtai-20240630.xsd (EX-101.SCH) — 43KB
- jtai-20240630_cal.xml (EX-101.CAL) — 64KB
- jtai-20240630_def.xml (EX-101.DEF) — 231KB
- jtai-20240630_lab.xml (EX-101.LAB) — 393KB
- jtai-20240630_pre.xml (EX-101.PRE) — 310KB
- forms-1a_htm.xml (XML) — 1403KB
RISK FACTORS
RISK FACTORS 10 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 26
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 28
BUSINESS
BUSINESS 57 DIRECTORS AND EXECUTIVE OFFICERS 68
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 74 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 86
USE OF PROCEEDS
USE OF PROCEEDS 92 DETERMINATION OF OFFERING PRICE 93 DIVIDEND POLICY 93 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 93
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 94 SELLING STOCKHOLDER 95 PLAN OF DISTRIBUTION 96
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 97 LEGAL MATTERS 101 EXPERTS 101 WHERE YOU CAN FIND MORE INFORMATION 101 INDEX TO FINANCIAL STATEMENTS F-1 2 ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the "SEC") pursuant to which the Selling Stockholder may, from time to time, offer and sell or otherwise dispose of the shares of our Common Stock covered by this prospectus. We will not receive any proceeds from the sale by the Selling Stockholder of the Shares offered by them described in this prospectus. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part. The prospectus supplement or post-effective amendment may add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. The registration in this prospectus. You should read this prospectus, any post-effective amendment, and any applicable prospectus supplement and the related exhibits filed with the SEC before making your investment decision. The registration statement and the exhibits can be obtained from the SEC, as indicated under the section entitled "Where You Can Find More Information." You should rely only on the information contained in this prospectus. Neither we nor the Selling Stockholder have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any post-effective amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred y